Nestlé is to develop so-called ‘functional foods’, which are designed to prevent and treat diseases including obesity and diabetes, but are not registered as pharmaceuticals.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.